Lakewood-Amedex Biotherapeutics
LABT
#10810
Rank
HK$46.8 M
Marketcap
HK$26.74
Share price
83.33%
Change (1 day)
N/A
Change (1 year)
Categories

Revenue for Lakewood-Amedex Biotherapeutics (LABT)

Revenue in 2026 (TTM): N/A

In 2025 the company made a revenue of N/A a decrease over the revenue in the year 2024 that were of N/A. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Lakewood-Amedex Biotherapeutics from 2023 to 2026

Annual revenue

Year Revenue Change
2026 (TTM) N/A
2025 N/A
2024 N/A
2023N/A